Trifocal IOL a key for premium cataract surgery practice

Cathleen M. McCabe, MD, chief medical officer, Eye Health America, and medical director, The Eye Associates, Bradenton, FL, said she began using the IOL as soon as it became available and estimates that she had already implanted it in several hundred eyes within the first six months. Dr. Braga-Mele...

Full description

Saved in:
Bibliographic Details
Published inOphthalmology Times Vol. 45; no. 8; pp. 15 - 16
Main Author McCabe, Cathleen M
Format Trade Publication Article
LanguageEnglish
Published Monmouth Junction MultiMedia Healthcare Inc 01.05.2020
Subjects
Astigmatism
Consultants
Diabetic retinopathy
Glaucoma
Medical personnel
Ophthalmology
Patient satisfaction
Planning
Presbyopia
Surgeons
Surgery
Canada
Online AccessGet full text

Cover

More Information
Summary:Cathleen M. McCabe, MD, chief medical officer, Eye Health America, and medical director, The Eye Associates, Bradenton, FL, said she began using the IOL as soon as it became available and estimates that she had already implanted it in several hundred eyes within the first six months. Dr. Braga-Mele said that she also discusses dysphotopsias with patients, but that the PanOptix IOL seems to be associated with a little better profile than bifocal lenses when it comes to halo and glare. Because it splits light to different foci, reduced contrast sensitivity is another issue to consider. [...]Dr. Braga-Mele and Dr. McCabe exclude patients as candidates for the lens if they have glaucoma or macular pathology affecting vision now or if there is a real risk for progression.
ISSN:0193-032X
2150-7333